Ischemic stroke laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Aysha Aslam (talk | contribs) |
Aysha Aslam (talk | contribs) |
||
| Line 11: | Line 11: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Complete blood count | | style="padding: 5px 5px; background: #F5F5F5;" |[[Complete blood count|'''Complete blood count''']] | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* To look for underlying infection (leukocytosis) | * To look for underlying infection (leukocytosis), [[Thrombocytosis]] and [[thrombocytopenia|thrombocytopenia,]] [[Polycythemia]] | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Lipid profile | | style="padding: 5px 5px; background: #F5F5F5;" |[[Lipid profile|'''Lipid profile''']] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Increased LDL, triglycerides and cholesterol increases risk for ischemic stroke | | style="padding: 5px 5px; background: #F5F5F5;" |Increased [[LDL]], [[triglycerides]] and [[cholesterol]] increases risk for ischemic stroke | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |PT/APTT | | style="padding: 5px 5px; background: #F5F5F5;" |[[PT|'''PT''']]'''/[[APTT]]/[[INR]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |To rule out underlying bleeding risk for anticoagulant administration | | style="padding: 5px 5px; background: #F5F5F5;" |To rule out underlying bleeding risk for anticoagulant administration | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |BUN/Creatinine | | style="padding: 5px 5px; background: #F5F5F5;" |[[BUN|'''BUN''']]'''/[[Creatinine]]''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Renal function tests to look for underlying kidney disease | | style="padding: 5px 5px; background: #F5F5F5;" |Renal function tests to look for underlying kidney disease | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Serum homocystein level | | style="padding: 5px 5px; background: #F5F5F5;" |'''Serum [[Homocysteine|homocystein]] level''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Increased levels associated with increased risk of thromboembolic event | | style="padding: 5px 5px; background: #F5F5F5;" |Increased levels associated with increased risk of thromboembolic event | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |[[Basic metabolic panel|'''Basic metabolic panel''']] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |To rule out electrolyte abnormalities which may mimic or complicate ischemic stroke | | style="padding: 5px 5px; background: #F5F5F5;" |To rule out electrolyte abnormalities which may mimic or complicate ischemic stroke | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |HbA1C | | style="padding: 5px 5px; background: #F5F5F5;" |[[HbA1C|'''HbA1C''']] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Underlying diabetes mellitus, major risk factor for ischemic stroke | | style="padding: 5px 5px; background: #F5F5F5;" |Underlying [[diabetes mellitus]], major risk factor for ischemic stroke | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Blood glucose levels | | style="padding: 5px 5px; background: #F5F5F5;" |'''Blood glucose levels''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Hyperglycemia is associated with poor prognosis of ischemic stroke | | style="padding: 5px 5px; background: #F5F5F5;" |[[Hyperglycemia]] is associated with poor prognosis of ischemic stroke | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Cardiac enzymes | | style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiac enzymes|'''Cardiac enzymes''']] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |To rule out underlying coronary artery disease | | style="padding: 5px 5px; background: #F5F5F5;" |To rule out underlying [[Coronary heart disease|coronary artery disease]] | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Pregnancy test | | style="padding: 5px 5px; background: #F5F5F5;" |[[Pregnancy test|'''Pregnancy test''']] | ||
| style="padding: 5px 5px; background: #F5F5F5;" |To rule out pregnancy in female patients with ischemic stroke as t-PA is a class C agent. | | style="padding: 5px 5px; background: #F5F5F5;" |To rule out pregnancy in female patients with ischemic stroke as t-PA is a class C agent. | ||
|- | |- | ||
Revision as of 15:28, 15 November 2016
|
Ischemic Stroke Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ischemic stroke laboratory findings On the Web |
|
American Roentgen Ray Society Images of Ischemic stroke laboratory findings |
|
Risk calculators and risk factors for Ischemic stroke laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Laboratory Findings
Labortary tests may help determine the risk factors complications of ischemic stroke. Blood tests which may be performed include:
| Blood test | Reason |
|---|---|
| Complete blood count |
|
| Lipid profile | Increased LDL, triglycerides and cholesterol increases risk for ischemic stroke |
| PT/APTT/INR | To rule out underlying bleeding risk for anticoagulant administration |
| BUN/Creatinine | Renal function tests to look for underlying kidney disease |
| Serum homocystein level | Increased levels associated with increased risk of thromboembolic event |
| Basic metabolic panel | To rule out electrolyte abnormalities which may mimic or complicate ischemic stroke |
| HbA1C | Underlying diabetes mellitus, major risk factor for ischemic stroke |
| Blood glucose levels | Hyperglycemia is associated with poor prognosis of ischemic stroke |
| Cardiac enzymes | To rule out underlying coronary artery disease |
| Pregnancy test | To rule out pregnancy in female patients with ischemic stroke as t-PA is a class C agent. |